The estimated Net Worth of Paul Korner is at least $736 millier dollars as of 5 January 2017. Dr Korner owns over 6,130 units of Agile Therapeutics Inc stock worth over $82,481 and over the last 9 years he sold AGRX stock worth over $79,384. In addition, he makes $574,591 as Sr. VP & Chief Medical Officer at Agile Therapeutics Inc.
Dr has made over 1 trades of the Agile Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 6,130 units of AGRX stock worth $79,384 on 5 January 2017.
The largest trade he's ever made was selling 6,130 units of Agile Therapeutics Inc stock on 5 January 2017 worth over $79,384. On average, Dr trades about 681 units every 0 days since 2016. As of 5 January 2017 he still owns at least 54,623 units of Agile Therapeutics Inc stock.
You can see the complete history of Dr Korner stock trades at the bottom of the page.
Dr. Paul Korner M.B.A., M.D. is the Sr. VP & Chief Medical Officer at Agile Therapeutics Inc.
As the Sr. VP & Chief Medical Officer of Agile Therapeutics Inc, the total compensation of Dr D at Agile Therapeutics Inc is $574,591. There are 4 executives at Agile Therapeutics Inc getting paid more, with Alfred Altomari having the highest compensation of $1,301,370.
Dr D is 55, he's been the Sr. VP & Chief Medical Officer of Agile Therapeutics Inc since . There are 11 older and 3 younger executives at Agile Therapeutics Inc. The oldest executive at Agile Therapeutics Inc is Ajit Shetty, 73, who is the Independent Director.
Paul's mailing address filed with the SEC is 101, Poor Farm Road, Princeton, Mercer County, New Jersey, 08540, United States.
Over the last 11 years, insiders at Agile Therapeutics Inc have traded over $2,369,944 worth of Agile Therapeutics Inc stock and bought 24,967,253 units worth $79,522,957 . The most active insiders traders include Advisors Llcperceptive Life..., Ab Investor et Capital Iii Llc Care Capita.... On average, Agile Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $1,032,678. The most recent stock trade was executed by Alfred Altomari on 26 August 2022, trading 50,000 units of AGRX stock currently worth $22,500.
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Agile Therapeutics Inc executives and other stock owners filed with the SEC include: